April 22 (Reuters) – U.S. Food and Drug Administration staff
on Friday formulated voting questions on Sarepta Therapeutics
Inc’s muscle wasting drug, ahead of a highly
anticipated meeting of…
The post U.S. FDA staff sets voting questions for Sarepta’s muscle drug appeared first on NASDAQ.